Faculty of Health Sciences, Department of Nursing, Baskent University, Baglica Kampusu, Baglica, Ankara, Turkey.
Support Care Cancer. 2010 May;18(5):583-90. doi: 10.1007/s00520-009-0692-5. Epub 2009 Jul 10.
Oral agents for cancer treatment commonly are prescribed throughout the world. Since oral agents usually are self-administered or administered by lay caregivers, patient education is vital to help ensure that the oral agents are being stored, handled, and taken correctly. When oral agents are taken as prescribed and patients are well informed about signs and symptoms to report, patient outcomes are optimized. Patient education varies globally; consequently, there is a need for a consistent and comprehensive approach to educate patients about oral cancer treatment.
To create a teaching tool to be used with patients receiving oral cancer agents for worldwide use.
Six oncology nurse experts conducted a literature review and convened as an expert panel to draft a teaching tool for patients receiving oral cancer agents. The tool includes key assessment questions, generic education discussion points, drug-specific education, and evaluation questions to help ensure that patients/caregivers understand the information provided. Eighteen healthcare providers from 15 countries reviewed the tool for clarity and usefulness in practice by scoring each item in the teaching tool on a 0-10 scale ("0 = not at all to "10" = most clear/useful"). Items that scored 5 or below required comments. At the Multinational Association for Supportive Care in Cancer (MASCC) Symposium in 2008, the healthcare providers who reviewed the teaching tool met with the oncology nurse experts who had developed the tool to review the item scores and revise the tool as necessary.
All items on the teaching tool received high scores, with the exception of items on refilling prescriptions and insurance issues, which vary from country to country. There was consensus that the MASCC Teaching Tool for Patients Receiving Oral Agents for Cancer was ready to be used and further evaluated in clinical practice.
The MASCC Teaching Tool for Patients Receiving Oral Agents for Cancer is an available resource to assist healthcare providers assess and teach patients about oral cancer treatment.
在世界范围内，通常会开出用于癌症治疗的口服药物。由于口服药物通常是由患者自己或非专业护理人员服用，因此患者教育对于确保药物得到正确储存、处理和服用至关重要。如果患者按规定服用药物，并且对需要报告的症状有充分的了解，那么患者的治疗效果将得到优化。全球各地的患者教育情况各不相同；因此，需要采用一致且全面的方法来教育患者有关口服癌症治疗的知识。
创建一种教学工具，供全球范围内使用口服癌症药物的患者使用。
六名肿瘤护理专家进行了文献回顾，并召集了一个专家小组，起草了一份用于接受口服癌症药物的患者的教学工具。该工具包括关键评估问题、通用教育讨论要点、药物特定教育和评估问题，以帮助确保患者/护理人员理解提供的信息。来自 15 个国家的 18 名医疗保健提供者通过在 0-10 分制（“0 = 一点也不”到“10 = 最清楚/最有用”）上对教学工具中的每个项目进行评分，对工具的清晰度和在实践中的实用性进行了审查。评分在 5 分或以下的项目需要评论。在 2008 年多国支持性护理协会（MASCC）研讨会上，审查教学工具的医疗保健提供者与开发该工具的肿瘤护理专家会面，审查项目评分并根据需要修改工具。
教学工具上的所有项目都获得了高分，除了与处方续配和保险问题相关的项目，这些问题因国家而异。大家一致认为，MASCC 口服癌症药物患者教学工具已经准备好用于临床实践，并进一步进行评估。
MASCC 口服癌症药物患者教学工具是一种可供医疗保健提供者使用的资源，可用于评估和教育患者有关口服癌症治疗的知识。
